Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2018-12-06
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Level vs Semen Parameters
NCT03167008
Effect of Liver Cirrhosis on Semen Parameters and Reproductive Hormones
NCT03167749
Role of Nutritional Support in Idiopathic Male Infertility
NCT03588949
Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome
NCT03129243
The Impact of Sinopharm COVID-19 Vaccination on Male Fertility
NCT04946565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First group: semen parameter showing normospermic
* group will include 30 male
* Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
* blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
ELISA to evaluate serum and seminal vitamin D level
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
second group: semen parameter asthenozoospermic
* group will include 30 male
* Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
* blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
ELISA to evaluate serum and seminal vitamin D level
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Third group: semen parameter oligozoospermic
* group will include 30 male
* Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
* blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
ELISA to evaluate serum and seminal vitamin D level
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Forth groupsemen parameter: astheno-teratozoospermic,
* group will include 30 male
* Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
* blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
ELISA to evaluate serum and seminal vitamin D level
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Fifth group semen parameter: oligo asthenoteratozoospermia
* group will include 30 male
* Semen samples will be collected from all patients Semen analysis will be examined after 2-5 days of sexual abstinence based on World Health Organization (WHO) (2010)
* blood and semen sample will be collected from all males to evaluate vitamin D level by ELISA .
ELISA to evaluate serum and seminal vitamin D level
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ELISA to evaluate serum and seminal vitamin D level
Serum and semen samples will be collected from all participant males and ELISA method used to evaluate the level of vitamin D in serum and semen
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 20-50 years
Exclusion Criteria
2. Genital tract infections.
3. Primary and secondary hypogonadism
4. Hormonal therapy.
5. Calcium and vitamin D supplement.
6. Hepatic or renal failure
7. Diseases or drugs affecting vitamin D absorption -
20 Years
50 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary Yonan
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Younan, Resident
Role: PRINCIPAL_INVESTIGATOR
Assiut Univeristy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Blomberg Jensen M, Jorgensen A, Nielsen JE, Bjerrum PJ, Skalkam M, Petersen JH, Egeberg DL, Bangsboll S, Andersen AN, Skakkebaek NE, Juul A, Rajpert-De Meyts E, Dissing S, Leffers H, Jorgensen N. Expression of the vitamin D metabolizing enzyme CYP24A1 at the annulus of human spermatozoa may serve as a novel marker of semen quality. Int J Androl. 2012 Aug;35(4):499-510. doi: 10.1111/j.1365-2605.2012.01256.x. Epub 2012 Mar 9.
Esteves SC. Clinical relevance of routine semen analysis and controversies surrounding the 2010 World Health Organization criteria for semen examination. Int Braz J Urol. 2014 Jul-Aug;40(4):443-53. doi: 10.1590/S1677-5538.IBJU.2014.04.02.
Hammoud AO, Meikle AW, Peterson CM, Stanford J, Gibson M, Carrell DT. Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian J Androl. 2012 Nov;14(6):855-9. doi: 10.1038/aja.2012.77. Epub 2012 Oct 8.
Herrmann M, Farrell CL, Pusceddu I, Fabregat-Cabello N, Cavalier E. Assessment of vitamin D status - a changing landscape. Clin Chem Lab Med. 2017 Jan 1;55(1):3-26. doi: 10.1515/cclm-2016-0264.
Yan WJ, Yu N, Yin TL, Liu L, Yang J. Can Vitamin D supplementation be used as adjunctive treatment for oligozoospermia or asthenozoospermia accompanied with Vitamin D deficiency? Asian J Androl. 2015 Jan-Feb;17(1):165-7. doi: 10.4103/1008-682X.138190. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SSVDSS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.